Delivery Order SPE2DB22D1103-SPE2DB25FTGF0

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order valued at $6,141.24 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of February 18, 2025 and is a firm fixed-price contract. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,587.77 firm-fixed-price delivery order is for the supply of Jardiance 10 mg tablets, a medication used to manage diabetes. The contract has an ultimate completion date of August 12, 2024. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $31,200.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,132.72 firm fixed-price delivery order is for the supply of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 3, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,940.65 firm fixed-price delivery order is for the supply of Jardiance 10 mg tablet, a medication used to treat diabetes. The contract has an ultimate completion date of October 13, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which AmerisourceBergen holds with...
This federal contract award, valued at $62,916.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. The...
This federal contract award, valued at $11,772.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat type 2 diabetes. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $5,032.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of JARDIANCE 10 MG TABLET 90S, a medication used for the treatment of diabetes. The contract has a completion date of December 4, 2024 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $3,520.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award, valued at $8,921.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm-fixed-price delivery order for the supply of Jardiance 10 mg tablets, a medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTGF0
    Delivery Order

This federal contract award, valued at $14,475.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of March 3, 2025 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/30/25, 10:03 AM